Heart failure
Conditions
Interventions
Control group:Traditional standardized heart failure management and regular follow-up
Experimental group:Smart wearable devices combined with PPC model
Sponsors
Rugao People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for chronic heart failure as outlined in the "2024 Guidelines for the Diagnosis and Treatment of Heart Failure in China" , which includes typical symptoms and signs of heart failure, with a left ventricular ejection fraction (LVEF) of = 400 pg/mL or BNP >= 100 pg/mL 5. Possess basic operating skills for smartphones or tablet computers, or have family members assist in operation 6. Expected survival duration >=12 months
Exclusion criteria
Exclusion criteria: 1. Patients with acute heart failure in the acute phase or with unstable hemodynamics 2. Patients with severe valvular heart disease requiring surgical intervention 3. Patients with severe hepatic and renal insufficiency (serum creatinine >265 µmol/L, ALT or AST levels exceeding three times the upper limit of normal) 4. Patients with concurrent malignant tumors or other severe systemic diseases, with an expected survival of less than 12 months 5. Patients with mental illness or cognitive dysfunction, unable to cooperate with treatment and follow-up 6. Pregnant or lactating women 7. Patients who have participated in other clinical trials within the past three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of heart failure-related clinical events within 12 months ;Vital signs and activity indicators; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac function indicators;Biochemical indicators;Medication adherence indicators; | — |
Countries
China
Contacts
Public ContactLiu Xiaoli
Rugao People's Hospital
Outcome results
None listed